David Lebwohl Exercises Options at Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 03, 2025

SEC Form 4 · No Market Transaction
Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner
TXN 2025-01-01 · FILED 2025-01-03
Equity Position 97.2K sh 94,034 → 97,223
Equity Change +3.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2025-01-03
Report Date
2025-01-01
Accession No.
0000950170-25-001237
Accepted At
2025-01-03 21:30 UTC
Reporting Owner
Name Relationship
David Lebwohl CIK 0001810882
EVP
David Lebwohl at Intellia Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $109,627
More from this insider at Intellia Therapeutics Inc
2026-03-03 Award — View
2026-01-07 Sell -$109,627 View
2025-03-04 Award — View
2025-01-07 Sell -$116,404 View
2024-03-05 Award — View
All filings by this insider at Intellia Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2025-01-01 M - Exercise 3,189 A — 97,223 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Stock UnitF1F3 2025-01-01 M - Exercise 3,189 D $0.00 2031-03-02 3,189 Common Stock Direct
Footnotes (3)
F1
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Show more
F2
Includes 405 and 556 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024, respectively. Show more
F3
On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter. Show more
5%+ Holders · 13D/G 5 filers
Other insiders at Intellia Therapeutics Inc
All Intellia Therapeutics Inc insider activity
GET /v1/forms/4/0000950170-25-001237 API docs
View Original SEC Filing